» Authors » Clarisa Gracia

Clarisa Gracia

Explore the profile of Clarisa Gracia including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 728
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gracia C, Brooks M, Goldstein J, Kalra S
Fertil Steril . 2025 Jan; PMID: 39842620
American Society for Reproductive Medicine develops evidence-based practice guidelines through a rigorous process of identifying clinically significant questions, conducting systematic literature reviews, and evaluating evidence quality. The evidence-based recommendations in...
2.
Applebaum J, Humphries L, Kravitz E, Taberski S, Koelper N, Gracia C, et al.
Fertil Steril . 2023 Dec; 121(3):452-459. PMID: 38043842
Objective: To investigate coronavirus disease 2019 (COVID-19) vaccination on the live birth rates in patients who underwent in vitro fertilization. Design: Retrospective cohort study. Setting: Academic fertility practice. Patient(s): Patients...
3.
Hill-Kayser C, Yorke E, Jackson A, Gracia C, Ginsberg J, Keene K, et al.
Int J Radiat Oncol Biol Phys . 2023 Oct; 119(2):588-609. PMID: 37804257
Purpose: The PENTEC (Pediatric Normal Tissue Effects in the Clinic) task force aimed to quantify effects of radiation therapy (RT) dose to the female reproductive organs after treatment for childhood...
4.
Huttler A, Koelper N, Mainigi M, Gracia C, Senapati S
F S Rep . 2022 May; 3(2):145-152. PMID: 35529036
Objective: To assess the impact of the COVID-19 pandemic on attitudes toward planned oocyte cryopreservation (OC). Design: Cross-sectional study. Setting: Internet-based survey questionnaire distributed nationally. Patients: One thousand women aged...
5.
Baker V, Glassner M, Doody K, Schnell V, Gracia C, Shin S, et al.
Fertil Steril . 2021 Apr; 116(2):575-582. PMID: 33812650
Objective: To evaluate the diagnostic performance of the antimüllerian hormone (AMH) level determined using the Access AMH assay for predicting poor ovarian response (POR) defined as ≤4 oocytes retrieved, including...
6.
Mulder R, Font-Gonzalez A, van Dulmen-den Broeder E, Quinn G, Ginsberg J, Loeffen E, et al.
Lancet Oncol . 2021 Feb; 22(2):e68-e80. PMID: 33539755
Patients with childhood, adolescent, and young adult cancer who will be treated with gonadotoxic therapies are at increased risk for infertility. Many patients and their families desire biological children but...
7.
Chemerinski A, Cameron K, Sammel M, Ginsberg J, Carlson C, Gracia C
J Cancer Surviv . 2020 Apr; 14(5):607-613. PMID: 32323140
Purpose: This study sought to evaluate the prevalence of menopausal symptoms in a population of reproductive-aged women remote from cancer therapy compared with a group of healthy similar-aged controls and...
8.
Alur-Gupta S, Hopeman M, Berger D, Barnhart K, Senapati S, Gracia C
Fertil Res Pract . 2020 Apr; 6:6. PMID: 32313664
Background: Given no consensus in the literature, this study sought to determine if a protocol of measuring serum estradiol and progesterone the day prior to frozen embryo transfer (FET) improves...
9.
Cameron K, Sammel M, Prewitt M, Gracia C
J Clin Endocrinol Metab . 2018 Dec; 104(5):1813-1822. PMID: 30566616
Context: Recent studies have examined level and rate of change of anti-Müllerian hormone (AMH) for predicting time to menopause. Limited prospective, longitudinal data exists evaluating measures of ovarian reserve (MOR)...
10.
Smith B, Duncan F, Ataman L, Smith K, Quinn G, Chang R, et al.
Future Oncol . 2018 Nov; 14(29):3059-3072. PMID: 30474429
Once unimaginable, fertility management is now a nationally established part of cancer care in institutions, from academic centers to community hospitals to private practices. Over the last two decades, advances...